These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients. Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953 [TBL] [Abstract][Full Text] [Related]
5. Antibody response to hepatitis C virus infection after liver transplantation. Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818 [TBL] [Abstract][Full Text] [Related]
6. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion". Ragni MV; Ndimbie OK; Rice EO; Bontempo FA; Nedjar S Blood; 1993 Aug; 82(3):1010-5. PubMed ID: 7687887 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection in kidney transplant recipients. Lau JY; Davis GL; Brunson ME; Qian KP; Lin HJ; Quan S; DiNello R; Polito AJ; Scornik JC Hepatology; 1993 Nov; 18(5):1027-31. PubMed ID: 7693567 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation. Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus. Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993 [TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III. Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329 [TBL] [Abstract][Full Text] [Related]
12. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Monteleone PM; Andrzejewski C; Kelleher JF Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047 [TBL] [Abstract][Full Text] [Related]
15. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors. Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study. Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836 [TBL] [Abstract][Full Text] [Related]
18. Characterization of differential antibody production against hepatitis C virus in different HCV infection status. Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N Virol J; 2016 Jun; 13():116. PubMed ID: 27357382 [TBL] [Abstract][Full Text] [Related]
19. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation. Teo CG; Gabriel FG; Mortimer PP J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients. Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]